Latest Financials News

Superloop Limited has delivered a standout FY25 with strong revenue growth and a positive net profit after tax, accelerated by strategic acquisitions and market share gains. The company sets an ambitious FY26 guidance, underpinned by a new $300 million loan facility and expanding fibre footprint.

Torque Metals has reported a significant high-grade gold intercept at its HHH deposit in Western Australia, hitting 5 metres at 15.2 grams per tonne gold. The company is now poised to advance exploration with downhole electromagnetic surveys to identify further mineralisation.

NEXTDC’s FY25 Annual General Meeting reveals robust financial growth, significant data centre expansions, and enhanced funding capacity to capitalise on AI infrastructure demand.

Charger Metals has initiated a 3,000m drilling program targeting a significant niobium anomaly at its Lake Johnston Lithium Project, funded by Rio Tinto Exploration. This move could unlock new battery metals potential alongside existing lithium and gold prospects.

Kairos Minerals reports strong gold intercepts from 14 new diamond drill holes at its Mt York Gold Project, extending high-grade zones and confirming the system remains open at depth. The company plans to deliver an updated Mineral Resource Estimate in Q1 2026 following its largest drilling campaign to date.

ReNerve Limited’s innovative NervAlign® Nerve Cuff has secured approval for use across the US Department of Defense and Veterans Affairs healthcare systems, marking a major milestone for the Australian medtech company.

SGH Ltd reported record earnings and reaffirmed its FY26 EBIT growth guidance at its 2025 AGM, while addressing recent workplace fatalities and outlining strategic growth initiatives.

Antilles Gold has launched a substantial infill drilling program at its La Demajagua mine in Cuba, setting the stage for a Definitive Feasibility Study that could unlock enhanced resource value amid soaring gold, silver, and antimony prices.

Anteris Technologies has gained FDA approval to start patient recruitment in the US for its pivotal PARADIGM Trial, following initial European regulatory success. The company advances manufacturing and clinical readiness as it pushes toward key regulatory milestones.

Anteris Technologies Global Corp. reported a $22.2 million loss in Q3 2025 while progressing its DurAVR Transcatheter Heart Valve pivotal trial following key regulatory approvals. The company bolstered its cash position with a $25.2 million private placement post-quarter.

Lycopodium Limited projects steady growth for FY26 with revenue guidance of $390-$410 million, underpinned by strong project momentum and the strategic SAXUM acquisition expanding its footprint in the Americas.

Locksley Resources is accelerating development at its Desert Antimony Mine in California, delivering promising high-grade bulk sample results and advancing towards U.S. antimony production aligned with federal strategic goals.